Výsledky vyhledávání - "Lis H. Poulsen"

A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders

Autor: Melissa P. DelBello, Philippe Auby, Grace Chen, Nora K. McNamara, Ole Lemming, Robert L. Findling, Russell E. Scheffer, Michael Huss, Elias H. Sarkis, Lis H. Poulsen, Adelaide S. Robb

Publikováno v: Journal of Child and Adolescent Psychopharmacology

Objectives: In this 6-month open-label extension (OLE) of NCT01491035 (a 14-day, open-label, pharmacokinetic/safety lead-in study), the long-term safety and tolerability of vortioxetine (5–20 mg/day) were investigated in children and adolescents wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba54c950b35f38477c1f0b83abf4429
https://doi.org/10.1089/cap.2017.0047

Zobrazit plný text záznamu

Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients

Autor: Adelaide S. Robb, Robert L. Findling, Lis H. Poulsen, Michael Huss, Melissa P. DelBello, Russell E. Scheffer, Johan Areberg, Elias H. Sarkis, Grace Chen, Nora K. McNamara, Ole Lemming, Philippe Auby

Publikováno v: Journal of Child and Adolescent Psychopharmacology

Objective: The primary objectives of this study were to evaluate the pharmacokinetics (PK) and tolerability of single and multiple doses of vortioxetine in children and adolescents with a depressive or anxiety disorder and to provide supportive infor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae4c86e52a0f0c4ccb987e9e05f04ae1
https://pubmed.ncbi.nlm.nih.gov/28333546

Zobrazit plný text záznamu

A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine

Autor: Stuart Montgomery, Rebecca Z. Nielsen, Lis H. Poulsen, Lars Häggström

Publikováno v: Human Psychopharmacology

Objective This randomised, double-blind, 12-week study compared efficacy and tolerability of flexible-dose treatment with vortioxetine (10–20 mg/day) versus agomelatine (25–50 mg/day) in major depressive disorder patients with inadequate response

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b52652026f153d7379aef2796d80b9cb
https://doi.org/10.1002/hup.2424

Zobrazit plný text záznamu

4.62 A SIX-MONTH OPEN-LABEL EXTENSION STUDY OF VORTIOXETINE IN PEDIATRIC PATIENTS

Autor: Michael Huss, Robert L. Findling, Russell E. Scheffer, Philippe Auby, Elias H. Sarkis, Melissa P. DelBello, Grace Chen, Nora K. McNamara, Adelaide S. Robb, Lis H. Poulsen, Ole Lemming

Publikováno v: Journal of the American Academy of Child & Adolescent Psychiatry. 55:S183

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dbd3107f443c55872648cf40d8c5c8af
https://doi.org/10.1016/j.jaac.2016.09.257

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání